MARKET

STAA

STAA

Staar Surg
NASDAQ
24.80
+1.24
+5.26%
After Hours: 24.81 +0.01 +0.04% 16:35 12/16 EST
OPEN
24.48
PREV CLOSE
23.56
HIGH
24.98
LOW
23.90
VOLUME
2.28M
TURNOVER
--
52 WEEK HIGH
30.81
52 WEEK LOW
13.50
MARKET CAP
1.23B
P/E (TTM)
-12.6718
1D
5D
1M
3M
1Y
5Y
1D
Yunqi Capital says remains opposed to STAAR’s proposed merger with Alcon
TipRanks · 12h ago
Press Release: Yunqi Capital Comments on Proxy Advisors' Updated Recommendations, Urges Shareholders to Continue to Back the Company's Standalone Trajectory
Dow Jones · 12h ago
Press Release: Yunqi Capital Comments on Proxy -2-
Dow Jones · 12h ago
*Staar Surgical: Increased Alcon Merger Price of $30.75 Per Shr Is Attractive Outcome for STAAR Stockholders >STAA
Dow Jones · 16h ago
*Staar Surgical: Independent Industry Analysts See Value to Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction >STAA
Dow Jones · 16h ago
STAAR Surgical Amends Alcon Merger Agreement to Offer $30.75 Per Share
Reuters · 16h ago
Press Release: Independent Industry Analysts -2-
Dow Jones · 16h ago
Press Release: Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction
Dow Jones · 16h ago
More
About STAA
STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. The Company markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). It also market and sell an ICL lens to treat hyperopia (farsightedness), called Visian ICL. It makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Company’s principal products are ICLs used in refractive surgery, including its EVO family of lenses.

Webull offers STAAR Surgical Co stock information, including NASDAQ: STAA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, STAA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading STAA stock methods without spending real money on the virtual paper trading platform.